Blogs
The latest from the Proscia blog: Every diagnosis is based on data that can change the course of drug development and patient care. With the growing adoption of digital pathology, laboratories are now generating a wealth of tissue images...
The latest from the Indica Labs blog Overview: The Clinical Trials Module in HALO AP Platforms The Clinical Trials module in HALO AP®, a CE-IVDR marked and AI-powered platform for primary diagnosis, and HALO AP Dx, an FDA-cleared...
From the Proscia blog: For HNL Lab Medicine, digital pathology isn’t just a technology upgrade—it’s a strategic business decision that has already delivered measurable gains. By partnering with Proscia, HNL Lab Medicine has not only...
From the Proscia blog: If you’re a diagnostic laboratory looking to go digital, then you’ve almost certainly thought about how your platform will integrate with your LIS. We sat down with Jacob Blaylock, our Senior Integration Engineer,...
The latest from the Proscia blog In a recent Today’s Clinical Lab webinar, our Chief Strategy Officer Nathan Buchbinder led a discussion on insights stemming from The 2025 Laboratory Leadership Report. He was joined by three of our...
Dr. Lal PathLabs: It accurately detected single-cell and micrometastases that had been missed during manual reviews. Results were later validated through IHC, confirming the system’s reliability Dr. Lal PathLabs (DLPL) has adopted a deep...
